Individuals with kind 1 diabetes can’t produce sufficient insulin to manage their blood sugar
Halfpoint Pictures/Getty Pictures
Researchers have 3D printed units product of insulin-producing cells. These units may allow a long-term therapy for kind 1 diabetes that might let folks produce their very own insulin – with out requiring invasive surgical procedure.
As a result of folks with kind 1 diabetes can not make sufficient insulin to manage their blood sugar, they need to consistently handle their situation, often with injections and dietary precautions. One longer-term therapy includes transplanting human islets – clusters of insulin-producing cells that sometimes develop within the pancreas – from donors. However like an organ transplant, this requires invasive surgical procedure.
“Present follow is to inject these human islets by way of the portal vein into the liver,” says Quentin Perrier on the Wake Forest Institute for Regenerative Drugs in North Carolina. Nonetheless, about half of the implanted islets rapidly lose their performance, which suggests folks should bear a number of transplantations to make the therapy efficient.
If islets might be positioned instantly underneath the pores and skin, surgical procedure wouldn’t solely be much less invasive, however it might additionally produce much less of the stress and irritation that shortens the cells’ useful life.
“The upper the density [of islets], the smaller the scale of the system you would wish to plant within the affected person,” says Adam Feinberg at Carnegie Mellon College in Pennsylvania and the biotech firm FluidForm Bio in Massachusetts.
To realize that top density, Perrier and his colleagues 3D printed islets from a “bioink” product of human pancreatic tissue and alginate, a sort of carbohydrate derived from seaweed. Dwell insulin-producing cells had been blended into this materials.
“We put this bioink with the [human] islet right into a syringe, and we print a particular motif [with it],” says Perrier. This porous grid is designed to permit new blood vessels to develop round and thru the construction.
Within the lab, this system “works very effectively”, says Perrier, noting that about 90 per cent of the islets’ cells survived and functioned for as much as three weeks. “The subsequent problem is de facto to validate this discovering in vivo.” Perrier and his colleagues introduced their analysis on the European Society for Organ Transplantation (ESOT) 2025 assembly in London on 29 June.
Feinberg and his colleagues have additionally 3D printed their very own islets. Their approach is to make a framework by printing cells and collagen instantly right into a hydrogel polymer – “sort of like 3D printing within hair gel”, he says. It was introduced on the Worldwide Pancreas & Islet Transplant Affiliation 2025 assembly in Pisa, Italy on 16 June. In diabetic lab mice, the islets restored regular glucose management for as much as six months.
Feinberg says Perrier’s work is “positively promising” however that the inherent variability of the human tissue used to make the islets may pose challenges in a residing physique. “It’s like getting a transplant organ,” he says. “On one facet, the fabric may match higher. On the flip facet, it’s variable and exhausting to get, and that’s a very exhausting downside to unravel.”
To keep away from such transplantation points, each Feinberg and Perrier say stem cell therapies characterize the way forward for kind 1 diabetes therapy. Utilizing stem cells within the 3D printing course of – as a substitute of the cells they’re at the moment utilizing – may remedy a number of points directly, they are saying.
Subjects:
